Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development

Eastern, Venezuelan, and Western equine encephalitis viruses (EEEV, VEEV, and WEEV) are encephalitic alphaviruses transmitted by mosquitoes throughout the Americas. Infection by these viruses can present in humans as a febrile illness; however, it may progress into potentially life-threatening encephalitis. Currently, no publicly licensed vaccines are available, and at-risk individuals are restricted to superseded vaccines. Here, we will review recent advances in our understanding of how these viruses spread among animal populations and cause disease, and how we can manage their diagnosis and treatment. Additionally, we have summarised the recent developments in vaccines against these viruses in both pre-clinical and clinical stages. Overall, global climate change and ecological disruption drive a need for public access to safe and effective vaccines against EEEV, VEEV, and WEEV, which novel platforms, such as mRNA and viral vectors, may be able to achieve.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-06-30
DOI
https://doi.org/10.3390/vaccines14070580
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development

Young Chan Kim, Sthefany Pagliari, Rose Gladman, George Eustace et al.
Vaccines
Mosquito-borne diseases and control
article

Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development

Young Chan Kim, Sthefany Pagliari, Rose Gladman, George Eustace, Yong Ji, Zoe de Zeeuw, Nouha Kisra
article en

Abstract

Eastern, Venezuelan, and Western equine encephalitis viruses (EEEV, VEEV, and WEEV) are encephalitic alphaviruses transmitted by mosquitoes throughout the Americas. Infection by these viruses can present in humans as a febrile illness; however, it may progress into potentially life-threatening encephalitis. Currently, no publicly licensed vaccines are available, and at-risk individuals are restricted to superseded vaccines. Here, we will review recent advances in our understanding of how these viruses spread among animal populations and cause disease, and how we can manage their diagnosis and treatment. Additionally, we have summarised the recent developments in vaccines against these viruses in both pre-clinical and clinical stages. Overall, global climate change and ecological disruption drive a need for public access to safe and effective vaccines against EEEV, VEEV, and WEEV, which novel platforms, such as mRNA and viral vectors, may be able to achieve.

VaccinesVol. 14(7)
Centre for Human Genetics (GB), University of Oxford (GB), Lincoln College (US), New College (GB)
Wellcome
Climate action
Openalex Percentile: Top 6%
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development — Young Chan Kim, Sthefany Pagliari, et al. · Vaccines (2026) | TGRS Research Map | TGRS